Posts tagged ‘Conference Coverage’
September 9th, 2011
Now that summer is officially over, the fall pharma/biotech conference season has started. You can find out details of the conferences Icarus Consultants will be attending by checking out our conference schedule.
If you are interested in our meeting coverage services or a conference report, please contact us.
This week, we followed two conferences remotely through Twitter. On Biotech Strategy Blog, Pieter Droppert aggregated the tweets from the BioPharm America 2011 partnering conference in Boston.
The joy of twitter is that you can follow the key messages of conference presenters remotely. It’s no substitute for being at the meeting and the networking opportunities in person, but it does allow you to capture a flavor of what everyone is thinking. 140 characters allows for a good sound bite!
Meanwhile on Pharma Strategy Blog, Sally Church has been following the ASCO Breast Cancer Symposium 2011 in San Francisco. Icarus Consultants will be at the San Antonio Breast Cancer Symposium (SABCS) later this year.
On Pharma Strategy Blog, Sally also wrote about the European Multidisciplinary Cancer Conference in Stockholm, more commonly known as ECCO or ESMO. The conference abstracts will be available on Monday, so we look forward to Sally’s video preview and thoughts on what’s hot at the meeting.
June 8th, 2011
Following on from an exciting American Society of Clinical Oncology (ASCO) meeting, this Friday sees the start of the 16th Congress of the European Hematology Association (EHA).
The annual EHA meeting runs from Friday June 10 through Sunday June 12, 2011 at the ExCeL conference center in London’s Docklands.
Sally Church will be traveling from Chicago to London, and aggregating tweets from the meeting on Pharma Strategy Blog (hashtag #EHA11). Should you be unable to attend, you can listen in on the conversation remotely.
Sally will also be publishing video blogs about the exciting scientific data presented at ASCO and EHA when she returns to New Jersey next week. Stay tuned!
April 2nd, 2011
Greetings from sunny Orlando and the AACR 102nd annual meeting 2011, one of the highlights of the year for those interested in the science of cancer and emerging new products.
For those of you who couldn’t afford a last minute Continental flight from Newark (does it really cost $600 to fly to Orlando?), Pharma Strategy Blog has a Covert it Live widget that aggregates all #AACR tweets.
While this is no substitute for actually attending, it does provide a window into what’s happening. Sally Church also plans to provide a daily video update, so watch Pharma Strategy Blog for the hot news from the American Association for Cancer Research annual meeting.
April 1st, 2011
We are excited to hear that Sally Church has produced another video to follow on from her recent video debut on Pharma Strategy Blog.
Produced by the aptly named, “PSB Films”, it is a trailer for her eagerly awaited post on “What’s hot at AACR 2011?”
Readers of Sally’s blog will know that prior to major scientific meetings such as AACR, ASCO and ASH, Sally often provides a mixture of commentary and insight on what she predicts will be hot topics.
Happy April 1st!
March 28th, 2011
As many of you know, Sally Church attended the recent European Association of Urology Congress in Vienna.
In the first video blog post that she’s ever done on Pharma Strategy Blog, she shares her impressions of the meeting and the changing landscape in advanced prostate cancer. One of the key new product approvals expected this year is for abiraterone.
We love the “BBC News” style graphics of her video blog, and look forward to hearing from Sally throughout the course of the year as she attends other conferences.
You can now watch Sally on her own YouTube channel. Will we see “Sally Church reporting live for Pharma Strategy Blog”?
March 18th, 2011
Sally Church on Pharma Strategy Blog will be providing live coverage of the annual European Association of Urology (EAU) Congress that starts in Vienna this weekend.
If you can’t join Sally at the meeting for a slice of schwarzwälder kirschtorte, then you can experience the meeting virtually as Sally aggregates all the live tweets, and contributes her own.
There are a lot of new products in the prostate cancer market. With new treatment options such as Dendreon’s sipuleucel-T, sanofi-aventis’ cabizatexel and JNJ’s abiraterone expected in the not too distant future, the meeting is bound to be interesting. We can also expect the latest news about new product development in bladder and renal cancer.
The Cover it Live widget on Sally’s blog will be aggregating all the tweets that use the conference hashtag #EAU11, so if you are unable to be in Vienna, you can follow what’s happening by clicking here.
March 8th, 2011
Icarus Consultants will be at the forthcoming European Urology Association annual meeting in Vienna, Austria from March 18-22, 2011.
If you are going to be in Vienna and would be interested in meeting up for Kaffee Und Kuchen, please contact us.
Incidentally, our favorite is a slice of Schwarzwälder Kirschtorte (Black Forest gateau).
February 24th, 2011
Sally Church on Pharma Strategy Blog will be providing live coverage of the AACR PI3-Kinase conference that starts today in San Francisco.
Sally AKA @MaverickNY will be live tweeting from the event that starts at 7pm (california time) today, Thursday, February 24 and runs through Sunday morning, February 27. The Cover it Live widget on her blog will be aggregating all the tweets that use the conference hashtag #PI3K, so if you are unable to be in San Francisco, you can follow what’s happening by clicking here.
This AACR special conference has an impressive line-up of leading key opinion leaders and experts in the field. The keynote session this evening is on “Targeting PI3K/mTOR in breast cancer” by Jose Baselga, from Mass General. The session chair is Lewis Cantley.
Some of the new products in development that will be discussed at the meeting include: GSK2126458, INK1117, AZD8055, MK-2206 and SAR245408 (XL147). If you are interested in purchasing an Icarus Consultants in-depth meeting report, do contact us.